AstraZeneca Reports a Strong Start to 2025 with a 7% Revenue Increase to $13.6 Billion

AstraZeneca announces a 7% revenue increase to $13.6 billion in Q1 2025, with product sales up by 6% and core operating profit growing by 12%. The company forecasts continued growt...